Effect of vitamin B12 and folic acid supplementation on biomarkers of endothelial function and inflammation among elderly individuals with hyperhomocysteinemia

Suzanne C van Dijk, Anke W Enneman, Karin MA Swart, Janneke P van Wijngaarden, Annelies C Ham, Robert de Jonge, Henk J Blom, Edith J Feskens, Johanna Marianne Geleijnse, Natasja M van Schoor, Rosalie AM Dhonukshe-Rutten, Renate T de Jongh, Paul Lips, Lisette CPGM de Groot, Andre G Uitterlinden, Ton H van den Meiracker, Francesco US Mattace-Raso, Nathalie van der Velde, Yvo M Smulders
2016-04-01
Abstract:B-vitamin trials failed to demonstrate beneficial effects on cardiovascular outcomes, but hyperhomocysteinemia still stands out as an independent cardiovascular risk factor, particularly in elderly individuals. B-vitamins may influence early vascular dysfunction, such as endothelial dysfunction, or may have adverse effects, for example on inflammation. We investigated the effect of B-vitamins on endothelial function and inflammation within an interventional study. This study was conducted within the framework of the B-PROOF trial, which included 2919 hyperhomocysteinemic elderly individuals, who received daily vitamin B12 (500 μg) and folic acid (400 μg) or placebo for 2 years. Using an electrochemiluminescence platform, we measured intercellular adhesion molecule 1 (ICAM-1), vascular adhesion molecule 1 (VCAM-1), serum amyloid A (SAA), vascular endothelial growth factor (VEGF) and C-reactive protein …
What problem does this paper attempt to address?